Neurotech Pharmaceuticals, Inc. Expands Executive Team with the Appointment of Scott Hunter as Chief Commercial Officer
Neurotech Pharmaceuticals, Inc., a clinical stage biotech company, today announced the expansion of its executive team with the appointment of Scott Hunter as Chief Commercial Officer bringing two decades of eyecare experience across both rare disease and specialty markets.
- Neurotech Pharmaceuticals, Inc., a clinical stage biotech company, today announced the expansion of its executive team with the appointment of Scott Hunter as Chief Commercial Officer bringing two decades of eyecare experience across both rare disease and specialty markets.
- View the full release here: https://www.businesswire.com/news/home/20230110005074/en/
Scott Hunter Joins Neurotech Pharmaceuticals as Chief Commercial Officer (Photo: Business Wire)
“Scott’s appointment as the Company’s first Chief Commercial Officer marks an important milestone for Neurotech. - Scott will be instrumental in helping us develop the commercial strategy and establish our commercial infrastructure,” said Richard Small, Chief Executive Officer of Neurotech.
- in Pharmacoeconomics from the University of Florida and his M.B.A. from the University of Tampa after completing his B.S.